O

OssDsign AB
STO:OSSD

Watchlist Manager
OssDsign AB
STO:OSSD
Watchlist
Price: 8.05 SEK 1.26% Market Closed
Market Cap: 786.2m SEK
Have any thoughts about
OssDsign AB?
Write Note

OssDsign AB
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OssDsign AB
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
O
OssDsign AB
STO:OSSD
Income from Continuing Operations
-kr130.5m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Income from Continuing Operations
kr204.3m
CAGR 3-Years
N/A
CAGR 5-Years
77%
CAGR 10-Years
41%
D
Doxa AB
STO:DOXA
Income from Continuing Operations
-kr208.2m
CAGR 3-Years
-145%
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Bactiguard Holding AB
STO:BACTI B
Income from Continuing Operations
-kr138.4m
CAGR 3-Years
-53%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Income from Continuing Operations
€972k
CAGR 3-Years
-75%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Income from Continuing Operations
-kr1.9m
CAGR 3-Years
54%
CAGR 5-Years
34%
CAGR 10-Years
N/A
No Stocks Found

OssDsign AB
Glance View

Market Cap
786.2m SEK
Industry
Health Care

OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

OSSD Intrinsic Value
10.3 SEK
Undervaluation 22%
Intrinsic Value
Price
O

See Also

What is OssDsign AB's Income from Continuing Operations?
Income from Continuing Operations
-130.5m SEK

Based on the financial report for Dec 31, 2023, OssDsign AB's Income from Continuing Operations amounts to -130.5m SEK.

What is OssDsign AB's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-18%

Over the last year, the Income from Continuing Operations growth was -31%. The average annual Income from Continuing Operations growth rates for OssDsign AB have been -16% over the past three years , -18% over the past five years .

Back to Top